Energage empowers organizations to optimize their workforce's performance and unlock their full potential.

Castle Creek Biosciences specializes in creating personalized gene therapies for rare skin disorders. Their innovative approach aims to develop and bring to market unique treatments for these conditions.

Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies. Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets.

Melior Discovery provides a pharmacology platform that uncovers new uses for early-stage drug candidates. Their innovative approach helps identify potential indications for further development, making drug discovery more efficient and effective.

Agronomed Pharmaceuticals cultivates, processes, and supplies high-quality cannabis-based health products. Committed to enhancing wellness, the company leverages innovative techniques to deliver effective and reliable solutions for health-conscious consumers seeking natural alternatives.

KinderPharm is a dedicated pediatric contract research organization (CRO) specializing in pediatric drug development. By collaborating closely with partners, KinderPharm advances innovative pediatric products through every stage of the development process, ensuring the unique needs of children are met in healthcare advancements.

Praeventix develops innovative therapies for bowel diseases, aiming to revolutionize treatment options. Their groundbreaking approach offers hope for patients and the potential for significant medical advancements in the field.

uTu connects brands with their target audiences through interactive channels. Their platform facilitates engaging conversations to drive brand awareness and customer loyalty.

Spherix Global Insights is a market research firm providing business intelligence services. Specializing in healthcare, they offer valuable insights to help companies make informed decisions.

OneSky Systems creates cutting-edge platforms for managing drone traffic and enabling urban air transportation. Their technology revolutionizes airspace management and paves the way for safe and efficient drone operations in urban environments.

COMSPOC offers a cutting-edge platform for space situational awareness by aggregating data from various commercial sensors to provide comprehensive and reliable information. Their services deliver unparalleled commercial SSA/STM solutions for enhanced space monitoring and management.

Energage empowers organizations to optimize their workforce's performance and unlock their full potential.

Spherix Global Insights is a market research firm providing business intelligence services. Specializing in healthcare, they offer valuable insights to help companies make informed decisions.

ONExia Robotics, founded in 2015, offers user-friendly robots with EASYreach Software for American manufacturers to enhance competitiveness. Robots are programmed through touch screen and hand controller interfaces.

Castle Creek Biosciences specializes in creating personalized gene therapies for rare skin disorders. Their innovative approach aims to develop and bring to market unique treatments for these conditions.

Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies. Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets.

Melior Discovery provides a pharmacology platform that uncovers new uses for early-stage drug candidates. Their innovative approach helps identify potential indications for further development, making drug discovery more efficient and effective.

Castle Creek Biosciences specializes in creating personalized gene therapies for rare skin disorders. Their innovative approach aims to develop and bring to market unique treatments for these conditions.

Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies. Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets.

Energage empowers organizations to optimize their workforce's performance and unlock their full potential.

Energage empowers organizations to optimize their workforce's performance and unlock their full potential.

Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies. Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets.

Castle Creek Biosciences specializes in creating personalized gene therapies for rare skin disorders. Their innovative approach aims to develop and bring to market unique treatments for these conditions.

Melior Discovery provides a pharmacology platform that uncovers new uses for early-stage drug candidates. Their innovative approach helps identify potential indications for further development, making drug discovery more efficient and effective.

Energage empowers organizations to optimize their workforce's performance and unlock their full potential.

Castle Creek Biosciences specializes in creating personalized gene therapies for rare skin disorders. Their innovative approach aims to develop and bring to market unique treatments for these conditions.

Spherix Global Insights is a market research firm providing business intelligence services. Specializing in healthcare, they offer valuable insights to help companies make informed decisions.